Search
News
ECDC statement following reported confirmed case of 2019-nCoV in Germany
ECDC statement following reported confirmed case of 2019-nCoV in Germany
Publication
Communicable disease threats to public health in the European Union - Annual Epidemiological Report for 2020
This report covers the events and threats detected by the ECDC epidemic intelligence (EI) team in 2020 and the actions taken in relation to these findings. The objective of EI at ECDC is to rapidly detect and assess public health events of any origin to ensure EU health security as defined in ECDC’s mandate.
Publication
Personal protective equipment (PPE) needs in healthcare settings for the care of patients with suspected or confirmed novel coronavirus (2019-nCoV)
The aim of this document is to support public health preparedness planning with regard to personal protective equipment (PPE) needs in healthcare settings where patients suspected or confirmed to have been infected with the novel coronavirus 2019-nCoV are being treated.
External Link
Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020
A first assessment looking at the preparedness of EU/EEA laboratories to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demonstrates a fast implementation of molecular diagnostics by the European specialised laboratory networks. It also shows a good geographical coverage for testing.
Publication
Coronavirus disease 2019 (COVID-19) data Reporting Protocol Version 6.2
This Reporting Protocol provides guidelines for data managers in reporting countries on how to prepare data for submission to TESSy, deadlines for reporting, subject-specific information (e.g. new changes to metadata), and links to further information.
Publication
Prevalence of post COVID-19 condition symptoms: a systematic review and meta-analysis of cohort study data, stratified by recruitment setting
The primary aim of this systematic review and meta-analysis was to estimate the prevalence of symptoms of post COVID-19 condition, stratified by recruitment setting (community, hospital and Intensive Care Unit (ICU)) as a proxy for disease severity.
Event
Online micro learning: What are the non-pharmaceutical countermeasures to minimise transmission of COVID-19?
ECDC offers micro learnings related to COVID-19 through the ECDC Virtual Academy.
Publication
Guidelines for the implementation of non-pharmaceutical interventions against COVID-19
These ECDC guidelines detail available options for NPI in various epidemiologic scenarios, assess the evidence for their effectiveness and address implementation issues, including potential barriers and facilitators.
Publication
Infection prevention and control and preparedness for COVID-19 in healthcare settings - sixth update
This document aims to provide guidance to EU/EEA healthcare facilities and healthcare providers on infection prevention and control (IPC) measures for the management of suspected and confirmed cases of COVID-19 infection in healthcare settings, including long-term care facilities. It also offers guidance on the management of specimens at laboratories in the EU/EEA.
Publication
Risk assessment: Outbreak of acute respiratory syndrome associated with a novel coronavirus, China: first local transmission in the EU/EEA − third update
On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China. On 9 January 2020, China CDC reported a novel coronavirus (2019-nCoV) as the causative agent of this outbreak, which is phylogenetically in the SARS-CoV clade.